Haleon Other Long-Term Assets 2023-2024 | HLN
Haleon other long-term assets from 2023 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Haleon other long-term assets for the quarter ending September 30, 2024 were $0M, a 100% decline year-over-year.
- Haleon other long-term assets for 2024 were $0.091B, a 59.25% decline from 2023.
- Haleon other long-term assets for 2023 were $0.223B, a 2.28% increase from 2022.
- Haleon other long-term assets for 2022 were $0.218B, a 0% decline from 2021.
| Haleon Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $91 |
| 2023 | $223 |
| 2022 | $218 |
| 2021 | $0 |
| Haleon Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-03-31 | |
| 2023-09-30 | |
| 2023-03-31 | |
| 2022-12-31 | $249 |
| 2022-06-30 | $110 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $47.240B | $14.355B |
| Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.146B | 27.67 |
| Boston Scientific (BSX) | United States | $150.504B | 37.68 |
| Stryker (SYK) | United States | $142.511B | 29.80 |
| EssilorLuxottica (ESLOY) | France | $130.598B | 0.00 |
| Medtronic (MDT) | Ireland | $110.517B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.287B | 0.00 |
| ResMed (RMD) | United States | $36.670B | 27.54 |
| Agilent Technologies (A) | United States | $32.977B | 21.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.574B | 15.47 |
| Terumo (TRUMY) | Japan | $26.206B | 34.04 |
| Insulet (PODD) | United States | $21.421B | 84.09 |
| Koninklijke Philips (PHG) | Netherlands | $20.782B | 14.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.848B | 11.46 |
| Baxter (BAX) | United States | $15.354B | 11.46 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.271B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $5.391B | 13.60 |
| Prestige Consumer Healthcare (PBH) | United States | $4.135B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.612B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.315B | 15.10 |
| ICU Medical (ICUI) | United States | $3.199B | 23.59 |
| Envista Holdings (NVST) | United States | $3.124B | 25.96 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.614B | 0.00 |
| Acuren (TIC) | United States | $1.361B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.66 |
| Neogen (NEOG) | United States | $1.146B | 14.67 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.57 |
| BioLife Solutions (BLFS) | United States | $1.033B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.845B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.774B | 0.00 |
| CeriBell (CBLL) | United States | $0.641B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Owens & Minor (OMI) | United States | $0.583B | 4.83 |
| Capricor Therapeutics (CAPR) | United States | $0.557B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.532B | 0.00 |
| Valneva SE (VALN) | France | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.331B | 58.80 |
| VAREX IMAGING (VREX) | United States | $0.320B | 11.77 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.233B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 54.95 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.28 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.72 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.26 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| United-Guardian (UG) | United States | $0.038B | 12.97 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |